1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Types of Cell Cultures
3.2.1. Primary Cell Cultures
3.2.2. Cell Lines
3.3. Morphology of Cells in Culture
3.4. Transition from 2D to 3D Cell Cultures
3.5. Overview of 3D Cell Culturing
3.5.1. Components of the Extracellular Matrix (ECM)
3.5.2. In Vitro Cell Culturing
3.5.3. Selection of Culture Format
3.6. Establishment and Maintenance of Cell Cultures
3.6.1. Isolating Cells from Tissues
3.6.2. Maintaining Cells in Culture
3.6.3. Sub-Culturing / Passaging
3.6.4. Cryogenic Storage
3.7. Requirements for Maintaining the Health of Cell Cultures
3.7.1. Safety Guidelines in a Cell Culture Facility
3.7.2. Cell Culture Health and Optimal Conditions for Growth
3.7.3. Concerns Related to Cross Contamination
3.7.4. Methods to Prevent Contamination
3.8. Need for 3D Cell Culture Systems
3.8.1. Model Systems
3.8.2. Drug Discovery and Preclinical Research
3.8.3. Cancer Research
3.8.4. Virology Research
3.8.5. Genetic Engineering and Gene Therapy Research
3.9. Advantages and Limitations of 3D Cell Culture Systems
3.10. Future Perspectives

4. CLASSIFICATION OF 3D CELL CULTURE SYSTEMS
4.1. 3D Cell Culture Classification
4.2. Scaffold based 3D Cell Cultures
4.2.1. Hydrogels / ECM Analogs
4.2.2. Solid Scaffolds
4.2.3. Micropatterned Surfaces
4.2.4. Microcarriers
4.3. Scaffold Free 3D Cell Cultures
4.3.1. Attachment Resistant Surfaces
4.3.2. Suspension Culture Systems
4.3.2.1. Hanging Drop Plates
4.3.2.2. Magnetic Levitation and 3D Bioprinting
4.3.3. Microfluidic Surfaces and Organs-on-Chips
4.3.4. 3D Bioreactors
4.4. Organoids

5. FABRICATION OF 3D MATRICES AND SCAFFOLDS
5.1. Chapter Overview
5.2. Methods for Fabricating Porous Scaffolds
5.2.1. Particulate Leaching
5.2.2. Solvent Casting
5.2.3. Emulsion Templating
5.2.4. Gas Foaming
5.2.5. Melt Molding
5.2.6. Microsphere Sintering
5.3. Methods for Fabricating Fibrous Scaffolds
5.3.1. Electrospinning
5.3.2. Phase Separation
5.3.3. Self-Assembly
5.3.4. Fiber Mesh and Fiber Bonding
5.4. Methods for Fabricating Hydrogels
5.4.1. Gelation
5.4.2. Solvent Casting and Particulate Leaching
5.4.3. Gas Foaming
5.4.4. Freeze Drying
5.4.5. Co-polymerization / Crosslinking Methods
5.4.6. Microfluidics
5.5. Methods for Fabricating Custom Scaffolds
5.5.1. Stereo-Lithography
5.5.2. 3D Bioprinting and Selective Laser Sintering (SLS)
5.5.3. Fused Deposition Modeling
5.5.4. Membrane Lamination
5.5.5. Rapid Prototyping / Solid Free-Form Technique
5.6. Methods for Fabricating Microspheres
5.6.1. Solvent Evaporation
5.6.2. Single and Double Emulsification
5.6.3. Particle Aggregation
5.7. Methods for Fabricating Native Scaffolds
5.7.1. Decellularization
6. 3D CELL CULTURE SYSTEMS: DEVELOPER LANDSCAPE
6.1. Chapter Overview
6.2. 3D Cell Culture System Developers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters
6.2.4. Analysis by 3D Cell Culture Format
6.2.5. Analysis by Type of Product
6.3. Heat Map Representation: Analysis by 3D Cell Culture Format and Location of Headquarters
6.4. Tree Map Representation: Analysis by Company Size and Type of Product
6.5. World Map Representation: Analysis by Location of Regional Headquarters
6.6. 3D Cell Cultures: List of Service Providers
6.7. 3D Cell Cultures: List of Assays, Kits and Reagents

7. MARKET LANDSCAPE: SCAFFOLD BASED PRODUCTS
7.1. Chapter Overview
7.2. Scaffold based Products: Overall Market Landscape
7.2.1. Analysis by Status of Development
7.2.2. Analysis by Type of Product
7.2.3. Analysis by Source of 3D Cultured Cells
7.2.4. Analysis by Method Used for Fabrication
7.2.5. Analysis by Material Used for Fabrication
7.2.6. Analysis by Type of Product and Source of 3D Cultured Cells
7.2.7. Analysis by Type of Product and Method Used for Fabrication
7.3. Scaffold Based Products: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.4. Leading Developers: Analysis by Number of Scaffold based Products
7.5. Tree Map Representation: Analysis by Type of Product and Company Size

8. MARKET LANDSCAPE: SCAFFOLD FREE PRODUCTS
8.1. Chapter Overview
8.2. Scaffold Free Products: Overall Market Landscape
8.2.1. Analysis by Status of Development
8.2.2. Analysis by Type of Product
8.2.3. Analysis by Source of 3D Cultured Cells
8.2.4. Analysis by Method Used for Fabrication
8.2.5. Analysis by Material Used for Fabrication
8.2.6. Analysis by Type of Product and Source of 3D Cultured Cells
8.2.7. Analysis by Type of Product and Method Used for Fabrication
8.3. Scaffold Free Products: Developer Landscape
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Location of Headquarters
8.4. Leading Developers: Analysis by Number of Scaffold Free Products
8.5. Tree Map Representation: Analysis by Type of Product and Company Size

9. MARKET LANDSCAPE: 3D BIOREACTORS
9.1. Chapter Overview
9.2. 3D Bioreactors: Overall Market Landscape
9.2.1. Analysis by Type of 3D Bioreactor
9.2.2. Analysis by Working Volume
9.3. 3D Bioreactors: Developer Landscape
9.3.1. Analysis by Year of Establishment
9.3.2. Analysis by Company Size
9.3.3. Analysis by Location of Headquarters
9.4. Leading Developers: Analysis by Number of 3D Bioreactors

10. KEY APPLICATION AREAS
10.1. Chapter Overview
10.2. 3D Cell Culture Systems in Cancer Research
10.2.1. Need for 3D Culture Systems in Cancer Research
10.2.1.1. Improving Cancer Drug Screening with 3D Culture Systems
10.3. 3D Cell Culture Systems in Drug Discovery and Toxicity Screening
10.3.1. Drug Development Studies
10.3.2. Toxicity Screening
10.3.2.1. 3D Liver Models
10.3.2.2. Other 3D Models
10.4. 3D Cell Culture Systems in Stem Cell Research
10.4.1. Potential of 3D Culture Systems in Stem Cell Differentiation
10.4.2. In Vitro 3D Microenvironment to Induce Embryoid Body Formation
10.5. 3D Cell Cultures in Regenerative Medicine and Tissue Engineering
10.6. 3D Cell Culture Systems: Analysis by Key Application Areas
10.6.1. 3D Cell Culture Systems: Analysis by Key Application Areas and 3D Cell Culture Format
10.6.1.1. Scaffold based 3D Products: Analysis by Key Application Areas
10.6.1.2. Scaffold Free 3D Products: Analysis by Key Application Areas
10.6.1.3. 3D Bioreactors: Analysis by Key Application Areas

11. COMPANY PROFILES: SCAFFOLD BASED PRODUCTS (HYDROGEL / ECM DEVELOPERS)
11.1. Chapter Overview
11.1.1. 3D Biotek
11.1.1.1. Company Overview
11.1.1.2. Product Portfolio
11.1.1.3. Recent Developments and Future Outlook
11.1.2. Advanced BioMatrix
11.1.2.1. Company Overview
11.1.2.2. Product Portfolio
11.1.2.3. Recent Development and Future Outlook
11.1.3. Alphabioregen
11.1.3.1. Company Overview
11.1.3.2. Product Portfolio
11.1.3.3. Recent Developments and Future Outlook
11.1.4. Corning Life Sciences
11.1.4.1. Company Overview
11.1.4.2. Product Portfolio
11.1.4.3. Recent Developments and Future Outlook
11.1.5. REPROCELL
11.1.5.1. Company Overview
11.1.5.2. Product Portfolio
11.1.5.3. Recent Developments and Future Outlook

12. COMPANY PROFILES: SCAFFOLD FREE PRODUCTS (ORGAN-ON-CHIP DEVELOPERS)
12.1. Chapter Overview
12.1.1. CN Bio Innovations
12.1.1.1. Company Overview
12.1.1.2. Financial Information
12.1.1.3. Product Portfolio
12.1.1.4. Recent Developments and Future Outlook
12.1.2. Emulate
12.1.2.1. Company Overview
12.1.2.2. Financial Information
12.1.2.3. Product Portfolio
12.1.2.4. Recent Developments and Future Outlook
12.1.3. InSphero
12.1.3.1. Company Overview
12.1.3.2. Financial Information
12.1.3.3. Product Portfolio
12.1.3.4. Recent Developments and Future Outlook
12.1.4. Mimetas
12.1.4.1. Company Overview
12.1.4.2. Financial Information
12.1.4.3. Product Portfolio
12.1.4.4. Recent Developments and Future Outlook
12.1.5. TissUse
12.1.5.1. Company Overview
12.1.5.2. Product Portfolio
12.1.5.3. Recent Developments and Future Outlook

13. COMPANY PROFILES: 3D BIOREACTORS
13.1. Chapter Overview
13.2. BISS TGT
13.2.1. Company Overview
13.2.2. Product Portfolio
13.2.3. Recent Developments and Future Outlook
13.3. Celartia
13.3.1. Company Overview
13.3.2. Product Portfolio
13.3.3. Recent Developments and Future Outlook
13.4. Cell Culture
13.4.1. Company Overview
13.4.2. Product Portfolio
13.4.3. Recent Developments and Future Outlook
13.5. Cesco Bioengineering
13.5.1. Company Overview
13.5.2. Product Portfolio
13.5.3. Recent Developments and Future Outlook
13.6. Flexcell International
13.6.1. Company Overview
13.6.2. Product Portfolio
13.6.3. Recent Developments and Future Outlook
13.7. PBS Biotech
13.7.1. Company Overview
13.7.2. Product Portfolio
13.7.3. Recent Developments and Future Outlook
13.8. Synthecon
13.8.1. Company Overview
13.8.2. Product Portfolio
13.8.3. Recent Developments and Future Outlook

14. FUNDING AND INVESTMENT ANALYSIS
14.1. Chapter Overview
14.2. Types of Funding
14.3. 3D Cell Culture Systems: Funding and Investment Analysis
14.3.1. Analysis by Number of Funding Instances
14.3.2. Analysis by Amount Invested
14.3.3. Analysis by Type of Funding
14.3.4. Analysis by 3D Cell Culture Format
14.3.5. Analysis by Type of Product
14.3.6. Analysis by Geography
14.3.7. Most Active Players: Analysis by Number of Funding Instances
14.3.8. Most Active Players: Analysis by Amount of Funding
14.3.9. Most Active Investors: Analysis by Number of Instances
14.4 Concluding Remarks

15. PARTNERSHIPS AND COLLABORATIONS
15.1. Chapter Overview
15.2. Partnership Models
15.3. 3D Cell Culture Systems: Recent Partnerships and Collaborations
15.3.1. Analysis by Year of Partnership
15.3.2. Analysis by Type of Partnership
15.3.2.1. Analysis by Year of Partnership and Type of Partnership
15.3.2.2. Analysis by Company Size and Type of Partnership
15.3.3. Analysis by Type of Partner
15.3.3.1. Analysis by Year of Partnership and Type of Partner
15.3.3.2. Analysis by Type of Partnership and Type of Partner
15.3.4. Analysis by 3D Cell Culture Format
15.3.4.1. Analysis by Year of Partnership and 3D Cell Culture Format
15.3.4.2. Analysis by Type of Partnership and 3D Cell Culture Format
15.3.5. Analysis by Type of Product
15.3.5.1. Analysis by Year of Partnership and Type of Product
15.3.5.2. Analysis by Type of Partnership and Type of Product
15.3.6. Most Active Players: Analysis by Number of Partnerships
15.3.7. Regional Analysis
15.3.8. Intercontinental and Intracontinental Agreements

16. PATENT ANALYSIS
16.1. Chapter Overview
16.2. Scope and Methodology
16.3. 3D Cell Culture Systems: Patent Analysis
16.3.1. Analysis by Type of Patent
16.3.2. Analysis by Publication Year
16.3.3. Analysis by Issuing Authority
16.3.4. Analysis by CPC Symbols
16.3.5. Emerging Focus Area
16.3.6. Leading Players: Analysis by Number of Patents
16.4. 3D Cell Culture Systems: Patent Valuation Analysis
16.5. Leading Patents: Analysis by Number of Citations

17. MARKET FORECAST
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Impact of COVID-19 Pandemic on Global 3D Cell Culture Market
17.4. Global 3D Cell Culture Market, 2020-2030
17.5. Global 3D Cell Culture Market: Distribution by Business Segment
17.5.1. 3D Cell Culture Systems Market, 2020-2030
17.5.2. 3D Cell Culture Consumables Market, 2020-2030
17.5.3. 3D Cell Culture Services Market, 2020-2030
17.6. Global 3D Cell Culture Systems Market: Distribution by 3D Cell Culture Format
17.6.1. 3D Cell Culture Systems Market for Scaffold based Products, 2020-2030
17.6.2. 3D Cell Culture Systems Market for Scaffold Free Products, 2020-2030
17.6.3. 3D Cell Culture Systems Market for 3D Bioreactors, 2020-2030
17.7. Global 3D Cell Culture Systems Market: Distribution by Type of Product
17.7.1. 3D Cell Culture Systems Market for Attachment Resistant Surfaces, 2020-2030
17.7.2. 3D Cell Culture Systems Market for Hydrogels / ECMs, 2020-2030
17.7.3 3D Cell Culture Systems Market for Micropatterned Surface, 2020-2030
17.7.4. 3D Cell Culture Systems Market for Microcarriers, 2020-2030
17.7.5. 3D Cell Culture Systems Market for Microfluidic Systems, 2020-2030
17.7.6. 3D Cell Culture Systems Market for Solid Scaffolds, 2020-2030
17.7.7. 3D Cell Culture Systems Market for Suspension Culture Systems, 2020-2030
17.8. Global 3D Cell Culture Systems Market: Distribution by Area of Application
17.8.1. 3D Cell Culture Systems Market for Cancer Research, 2020-2030
17.8.2 3D Cell Culture Systems Market for Drug Discovery and Toxicity Testing, 2020-2030
17.8.3. 3D Cell Culture Systems Market for Stem Cell Research, 2020-2030
17.8.4. 3D Cell Culture Systems Market for Regenerative Medicine and Tissue Engineering, 2020-2030
17.9. Global 3D Cell Culture Systems Market: Distribution by Purpose
17.9.1. 3D Cell Culture Systems Market for Research Use, 2020-2030
17.9.2 3D Cell Culture Systems Market for Therapeutic Use, 2020-2030
17.10. Global 3D Cell Culture Systems Market: Distribution by Geography
17.10.1. 3D Cell Culture Systems Market in North America, 2020-2030
17.10.2 3D Cell Culture Systems Market in Europe, 2020-2030
17.10.3. 3D Cell Culture Systems Market in Asia-Pacific, 2020-2030
17.10.4. 3D Cell Culture Systems Market in Latin America, 2020-2030
17.10.4. 3D Cell Culture Systems Market in Middle East and North Africa (MENA), 2020-2030
17.10.5. 3D Cell Culture Systems Market in Rest of the World, 2020-2030
17.11. Global 3D Cell Culture Systems Market: Distribution by Leading Players, 2020
17.12. Concluding Remarks

18. SURVEY ANALYSIS
18.1. Chapter Overview
18.2. Overview of Respondents
18.2.1. Designation of Respondents
18.3. Survey Insights
18.3.1. 3D Cell Culture Format
18.3.2. Type of Product(s) Offered
18.3.3. Status of Development of Product(s)
18.3.4. Source of 3D Cultured Cells
18.3.5. Method Used for Fabrication
18.3.6. Area(s) of Application
18.3.7. Services Offered for 3D Cell Cultures
18.3.8. Current and Future Market Opportunity

19. CONCLUSION

20. EXECUTIVE INSIGHTS
20.1. Chapter Overview
20.2. Cellendes
20.2.1. Company Snapshot
20.2.2. Interview Transcript: Brigitte Angres, Co-founder
20.3. Synthecon
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Bill Anderson, President and CEO
20.4. Anonymous
20.4.1. Interview Transcript: Anonymous, President and CEO
20.5. Anonymous
20.5.1. Interview Transcript: Anonymous, Co-founder and Vice President
20.6. BRTI Life Sciences
20.6.1. Company Snapshot
20.6.2. Interview Transcript: Scott Brush, Vice President
20.7. Kirkstall
20.7.1. Company Snapshot
20.7.2. Interview Transcript: Malcolm Wilkinson, Managing Director
20.8. QGel
20.8.1. Company Snapshot
20.8.2. Interview Transcript: Ryder Clifford, Director and Simone Carlo Rizzi, Chief Scientific Officer
20.9. Xylyx Bio
20.9.1. Company Snapshot
20.9.2. Interview Transcript: Tanya Yankelevich, Director
20.10. InSphero
20.10.1. Company Snapshot
20.10.2. Interview Transcript: Jens Kelm, Chief Scientific Officer
20.11. GSI
20.11.1. Company Snapshot
20.11.2. Interview Transcript: Walter Tinganelli, Group Leader
20.12. Nanofiber Solutions
20.12.1. Company Snapshot
20.12.2. Interview Transcript: Darlene Thieken, Project Manager

21. APPENDIX I: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures
Figure 3.1 Classification of Cell Cultures
Figure 3.2 Types of 2D and 3D Cell Culture Systems
Figure 3.3 Key Components of ECM
Figure 3.4 Factors Influencing the Selection of 3D Cell Culture Systems
Figure 3.5 Methods Used for Isolation of Cells from Tissues
Figure 3.6 Methods Used for Cryogenic Storage
Figure 3.7 Required Biosafety Levels for Cell Cultures
Figure 3.8 Key Applications of Cell Cultures
Figure 3.9 Shapes of 3D Spheroids Generated via 3D Cell Culture Systems
Figure 3.10 Advantages and Limitations of 3D Cell Culture Systems
Figure 4.1 Classification of 3D Cell Culture Systems
Figure 4.2 Natural Components of ECM Used for Fabrication of Scaffolds
Figure 4.3 Advantages and Disadvantages of Hydrogels
Figure 4.4 Advantages of Microcarriers
Figure 4.5 Techniques Used for Formation of 3D Spheroids
Figure 4.6 Structures of Spinner Flask and Rotating Wall Bioreactors
Figure 6.1 3D Cell Culture System Developers: Distribution by Year of Establishment
Figure 6.2 3D Cell Culture System Developers: Distribution by Company Size
Figure 6.3 3D Cell Culture System Developers: Distribution by Location of Headquarters
Figure 6.4 3D Cell Culture System Developers: Distribution by 3D Cell Culture Format
Figure 6.5 3D Cell Culture System Developers: Distribution by Type of Product
Figure 6.6 3D Cell Culture System Developers: Distribution by Number of 3D Cell Culture Products
Figure 6.7 Heat Map Representation: Distribution by 3D Cell Culture Format and Location of Headquarters
Figure 6.8 Tree Map Representation: Distribution by Company Size and Type of Product
Figure 6.9 World Map Representation: Distribution by Location of Regional Headquarters
Figure 7.1 Scaffold Based Products: Distribution by Status of Development
Figure 7.2 Scaffold Based Products: Distribution by Type of Product
Figure 7.3 Scaffold Based Products: Distribution by Source of 3D Cultured Cells
Figure 7.4 Scaffold Based Products: Distribution by Method Used for Fabrication
Figure 7.5 Scaffold Based Products: Distribution by Material Used for Fabrication
Figure 7.6 Scaffold Based Products: Distribution by Type of Product and Source of 3D Cultured Cells
Figure 7.7 Scaffold Based Products: Distribution by Type of Product and Method Used for Fabrication
Figure 7.8 Scaffold Based Product Developers: Distribution by Year of Establishment
Figure 7.9 Scaffold Based Product Developers: Distribution by Company Size
Figure 7.10 Scaffold Based Product Developers: Distribution by Location of Headquarters
Figure 7.11 Leading Developers: Distribution by Number of Scaffold Based Products
Figure 7.12 Tree Map Representation: Distribution by Type of Product and Company Size
Figure 8.1 Scaffold Free Products: Distribution by Status of Development
Figure 8.2 Scaffold Free Products: Distribution by Type of Product
Figure 8.3 Scaffold Free Products: Distribution by Source of 3D Cultured Cells
Figure 8.4 Scaffold Free Products: Distribution by Method Used for Fabrication
Figure 8.5 Scaffold Free Products: Distribution by Material Used for Fabrication
Figure 8.6 Scaffold Free Products: Distribution by Type of Product and Source of 3D Cultured Cells
Figure 8.7 Scaffold Free Products: Distribution by Type of Product and Method Used for Fabrication
Figure 8.8 Scaffold Free Product Developers: Distribution by Year of Establishment
Figure 8.9 Scaffold Free Product Developers: Distribution by Company Size
Figure 8.10 Scaffold Free Product Developers: Distribution by Location of Headquarters
Figure 8.11 Leading Developers: Distribution by Number of Scaffold Free Products
Figure 8.12 Tree Map Representation: Distribution by Type of Product and Company Size
Figure 9.1 3D Bioreactors: Distribution by Type of 3D Bioreactor
Figure 9.2 3D Bioreactors: Distribution by Working Volume
Figure 9.3 3D Bioreactor Developers: Distribution by Year of Establishment
Figure 9.4 3D Bioreactor Developers: Distribution by Company Size
Figure 9.5 3D Bioreactor Developers: Distribution by Location of Headquarters
Figure 9.6 Leading Developers: Distribution by Number of 3D Bioreactors
Figure 10.1 Key Application Areas of 3D Cell Culture Systems
Figure 10.2 3D Cell Culture Systems in Cancer Research
Figure 10.3 3D Cell Culture Systems in Drug Discovery and Toxicity Screening
Figure 10.4 Methods Used for Embryoid Body Formation
Figure 10.5 Top-Down and Bottom-Up Approaches for Tissue Engineering
Figure 10.6 3D Cell Culture Systems: Distribution by Key Application Areas
Figure 10.7 3D Cell Culture Systems: Distribution by Key Application Areas and 3D Cell Culture Format
Figure 10.8 Scaffold Based 3D Products: Distribution by Key Application Areas
Figure 10.9 Scaffold Free 3D Products: Distribution by Key Application Areas
Figure 10.10 3D Bioreactors: Distribution by Key Application Areas
Figure 13.1 Key Features of 3D Perfusion Bioreactors
Figure 13.2 MagDrive and AirDrive Mechanisms for PBS Bioreactors
Figure 13.3 Advantages of Rotary Cell Culture System (RCCS)
Figure 14.1 Funding and Investments: Distribution of Recipient Companies by Year of Establishment and Type of Funding, 2015-Q3 2020
Figure 14.2 Funding and Investments: Cumulative Number of Funding Instances by Year, 2015 - Q3 2020
Figure 14.3 Funding and Investments: Cumulative Amount Invested, 2015 - Q3 2020 (USD Million)
Figure 14.4 Funding and Investments: Distribution of Instances by Type of Funding, 2015 - Q3 2020
Figure 14.5 Funding and Investments: Year-Wise Distribution of Instances and Type of Funding, 2015 - Q3 2020
Figure 14.6 Funding and Investments: Distribution by Amount Invested and Type of Funding, 2015 - Q3 2020 (USD Million)
Figure 14.7 Funding and Investments: Year-Wise Distribution of Amount Invested and Type of Funding, 2015 - Q3 2020
Figure 14.8 Funding and Investments: Distribution by Number of Instances and Amount Invested by 3D Cell Culture Format, 2015 - Q3 2020
Figure 14.9 Funding and Investments: Distribution by Number of Instances and Amount Invested by Type of Product, 2015 - Q3 2020
Figure 14.10 Funding and Investments: Distribution by Geography
Figure 14.11 Funding and Investments: Regional Distribution by Total Amount Invested, 2015 - Q3 2020
Figure 14.12 Most Active Players: Distribution by Number of Funding Instances, 2015 - Q3 2020
Figure 14.13 Most Active Players: Distribution by Amount Raised, 2015 - Q3 2020 (USD Million)
Figure 14.14 Most Active Investors: Distribution by Number of Funding Instances, 2015-Q3 2020
Figure 14.15 Funding and Investment Summary, 2015 - Q3 2020 (USD Million)
Figure 15.1 Partnerships and Collaborations: Cumulative Year-Wise Trend, 2015 - Q3 2020
Figure 15.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 15.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 15.4 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Figure 15.5 Partnerships and Collaborations: Distribution by Type of Partner
Figure 15.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 15.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 15.8 Partnerships and Collaborations: Distribution by 3D Cell Culture Format
Figure 15.9 Partnerships and Collaborations: Distribution by Year of Partnership and 3D Cell Culture Format
Figure 15.10 Partnerships and Collaborations: Distribution by Type of Partnership and 3D Cell Culture Format
Figure 15.11 Partnerships and Collaborations: Distribution by Type of Product
Figure 15.12 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Product
Figure 15.13 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 15.14 Most Active Players: Distribution by Number of Partnerships
Figure 15.15 Partnerships and Collaborations: Regional Distribution
Figure 15.16 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Agreements
Figure 16.1 Patent Analysis: Distribution by Type of Patent
Figure 16.2 Patent Analysis: Cumulative Distribution by Publication Year, 2015 - Q3 2020
Figure 16.3 Patent Analysis: Distribution of Granted Patents by Publication Year, 2015 - Q3 2020
Figure 16.4 Patent Analysis: Distribution of Filed Patents Publication Year, 2015 - Q3 2020
Figure 16.5 Patent Analysis: Distribution by Patent Type and Publication Year, 2015 - Q3 2020
Figure 16.6 Patent Analysis: Distribution by Issuing Authority
Figure 16.7 Patent Analysis: Distribution by CPC Symbols
Figure 16.8 Patent Analysis: Distribution by Emerging Focus Area
Figure 16.9 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, 2015 - Q3 2020
Figure 16.10 Leading Patent Assignees (Industry Players): Distribution by Number of Patents
Figure 16.11 Leading Patent Assignees (Non-Industry Players): Distribution by Number of Patents
Figure 16.12 Patent Analysis: Distribution by Patent Age, 2000-2020
Figure 16.13 Patent Analysis: Distribution by Proprietary Scoring Criteria
Figure 16.14 Patent Analysis: Valuation Analysis
Figure 17.1 Global 3D Cell Culture Market, 2020-2030 (USD Million)
Figure 17.2 Global 3D Cell Culture Market: Distribution by Business Segment, 2020 and 2030
Figure 17.3 3D Cell Culture Systems Market, 2020-2030 (USD Million)
Figure 17.4 3D Cell Culture Consumables Market, 2020-2030 (USD Million)
Figure 17.5 3D Cell Culture Services Market, 2020-2030 (USD Million)
Figure 17.6. Global 3D Cell Culture Systems Market: Distribution by 3D Cell Culture Format, 2020-2030
Figure 17.7 3D Cell Culture Systems Market for Scaffold Based Products, 2020-2030 (USD Million)
Figure 17.8 3D Cell Culture Systems Market for Scaffold Free Products, 2020-2030 (USD Million)
Figure 17.9 3D Cell Culture Systems Market for 3D Bioreactors, 2020-2030 (USD Million)
Figure 17.10 Global 3D Cell Culture Systems Market: Distribution by Type of Product, 2020 and 2030
Figure 17.11 3D Cell Culture Systems Market for Attachment Resistant Surfaces, 2020-2030 (USD Million)
Figure 17.12 3D Cell Culture Systems Market for Hydrogels / ECMs, 2020-2030 (USD Million)
Figure 17.13 3D Cell Culture Systems Market for Micropatterned Surface, 2020-2030 (USD Million)
Figure 17.14 3D Cell Culture Systems Market for Microcarriers, 2020-2030 (USD Million)
Figure 17.15 3D Cell Culture Systems Market for Microfluidic Systems, 2020-2030 (USD Million)
Figure 17.16 3D Cell Culture Systems Market for Solid Scaffolds, 2020-2030 (USD Million)
Figure 17.17 3D Cell Culture Systems Market for Suspension Cultures, 2020-2030 (USD Million)
Figure 17.18 Global 3D Cell Culture Systems Market: Distribution by Area of Application, 2020 and 2030
Figure 17.19 3D Cell Culture Systems Market for Cancer Research, 2020-2030 (USD Million)
Figure 17.20 3D Cell Culture Systems Market for Drug Discovery and Toxicity Testing, 2020-2030 (USD Million)
Figure 17.21 3D Cell Culture Systems Market for Stem Cell Research, 2020-2030 (USD Million)
Figure 17.22 3D Cell Culture Systems Market for Regenerative Medicine and Tissue Engineering, 2020-2030 (USD Million)
Figure 17.23 Global 3D Cell Culture Systems Market: Distribution by Purpose, 2020-2030
Figure 17.24 3D Cell Culture Systems Market for Research Use, 2020-2030 (USD Million)
Figure 17.25 3D Cell Culture Systems Market for Therapeutic Use, 2020-2030 (USD Million)
Figure 17.26 Global 3D Cell Culture Systems Market: Distribution by Geography, 2020- 2030
Figure 17.27 3D Cell Culture Systems Market in North America, 2020-2030 (USD Million)
Figure 17.28 3D Cell Culture Systems Market in Europe, 2020-2030 (USD Million)
Figure 17.29 3D Cell Culture Systems Market in Asia-Pacific, 2020-2030 (USD Million)
Figure 17.30 3D Cell Culture Systems Market in Latin America, 2020-2030 (USD Million)
Figure 17.31 3D Cell Culture Systems Market in Middle East and North Africa (MENA), 2020-2030 (USD Million)
Figure 17.32 3D Cell Culture Systems Market in Rest of the World, 2020-2030 (USD Million)
Figure 17.33 Global 3D Cell Culture Systems Market: Distribution by Leading Players, 2020
Figure 17.34 Global 3D Cell Culture Systems Market: Conservative, Base and Optimistic Scenarios, 2020, 2025 and 2030 (USD Million)
Figure 18.1 Survey Insights: Distribution of Respondents by Year of Establishment of the Company
Figure 18.2 Survey Insights: Distribution of Respondents by Company Size
Figure 18.3 Survey Insights: Distribution of Respondents by Location of Company Headquarters (Region-Wise)
Figure 18.4 Survey Insights: Distribution of Respondents by Location of Company Headquarters (Country-Wise)
Figure 18.5 Survey Insights: Distribution of Respondents by Designation and Seniority Level
Figure 18.6 Survey Insights: Distribution by Focus Area
Figure 18.7 Survey Insights: Distribution by Type of 3D Cell Culture Products Offered
Figure 18.8 Survey Insights: Distribution by Status of Development of Product(s)
Figure 18.9 Survey Insights: Distribution by Method of Fabrication Used
Figure 18.10 Survey Insights: Distribution by Source of Cultured Cells
Figure 18.11 Survey Insights: Distribution by Key Applications
Figure 18.12 Survey Insights: Distribution by 3D Cell Culture Services Offered
Figure 18.13 Survey Insights: Distribution by Current and Future Market Opportunity, 2020 and 2030
Figure 19.1 3D Cell Culture Systems Market: Concluding Remarks

List of Tables
Table 3.1 Morphology of Cells in a Culture
Table 3.2 Differences between 2D and 3D Cell Cultures
Table 3.3 Features of 3D Spheroids generated via 3D Cell Culture Systems
Table 4.1 Advantages and Disadvantages of Scaffold Based and Scaffold Free Systems
Table 4.2 Advantages and Disadvantages of Natural and Synthetic Scaffolds
Table 4.3 Advantages and Disadvantages of Natural and Synthetic Hydrogels
Table 4.4 Cell Cultures Used in Magnetic Levitation
Table 4.5 Origin and Culture Techniques Used for Organoids
Table 5.1 Advantages and Disadvantages of Methods Used for Fabrication for Porous Scaffolds
Table 5.2 3D Cell Culture Studies Using Porous Scaffolds
Table 5.3 Methods for Fabrication Used of Fibrous Scaffolds
Table 5.4 Advantages and Disadvantages of Methods Used for Fabrication of Fibrous Scaffolds
Table 5.5 3D Cell Culture Studies Using Fibrous Scaffolds
Table 5.6 Advantages and Disadvantages of Methods Used for Fabrication of Hydrogels
Table 5.7 3D Cell Culture Studies Using Hydrogels
Table 5.8 Advantages and Disadvantages of Methods Used for Fabrication of Custom Scaffolds
Table 5.9 3D Cell Culture Studies Using Custom Scaffolds
Table 5.10 Advantages and Disadvantages of Methods Used for Fabrication of Microspheres
Table 5.11 3D Cell Culture Studies Using Microspheres
Table 5.12 3D Cell Culture Studies Using Native Scaffolds
Table 6.1 3D Cell Culture Systems: List of Developers
Table 6.2 3D Cell Culture Systems: List of Service Providers
Table 6.3 3D Cell Culture Systems: List of Assays, Kits and Reagents
Table 7.1 Scaffold Based Products: List of Products
Table 7.2 Scaffold Based Products: List of Developers
Table 8.1 Scaffold Free Products: List of Products
Table 8.2 Scaffold Free Products: List of Developers
Table 9.1 3D Bioreactors: List of Products
Table 9.2 3D Bioreactors: List of Developers
Table 10.1 Scaffold Based Products: Information on Key Application Areas
Table 10.2 Scaffold Free Products: Information on Key Application Areas
Table 10.3 3D Bioreactors: Information on Key Application Areas
Table 11.1 Scaffold Based Products (Hydrogel / ECM): List of Companies Profiled
Table 11.2 3D Biotek: Company Snapshot
Table 11.3 3D Biotek: Key Characteristics of Hydrogels / ECMs
Table 11.4 Advanced Biomatrix: Company Snapshot
Table 11.5 Advanced Biomatrix: Key Characteristics of Hydrogels / ECMs
Table 11.6 Advanced Biomatrix: Recent Developments and Future Outlook
Table 11.7 Alphabioregen: Company Snapshot
Table 11.8 Alphabioregen: Key Characteristics of Hydrogels / ECMs
Table 11.9 Corning Life Sciences: Company Snapshot
Table 11.10 Corning Life Sciences: Key Characteristics of Hydrogels / ECMs
Table 11.11 Corning Life Sciences: Recent Developments and Future Outlook
Table 11.12 REPROCELL: Company Snapshot
Table 11.13 REPROCELL: Key Characteristics of Hydrogels / ECMs
Table 11.14 REPROCELL: Recent Developments and Future Outlook
Table 12.1 Scaffold Free Products (Organ-on-Chip): List of Companies Profiled
Table 12.2 CN Bio Innovations: Company Snapshot
Table 12.3 CN Bio Innovations: Information on Funding Instances
Table 12.4 CN Bio Innovations: Key Characteristics of Organ-on-Chips Products
Table 12.5 CN Bio Innovations: Recent Developments and Future Outlook
Table 12.6 Emulate: Company Snapshot
Table 12.7 Emulate: Information on Funding Instances
Table 12.8 Emulate: Key Characteristics of Organ-on-Chips Products
Table 12.9 Emulate: Recent Developments and Future Outlook
Table 12.10 InSphero: Company Snapshot
Table 12.11 InSphero: Information on Funding Instances
Table 12.12 InSphero: Key Characteristics of Organ-on-Chips Products
Table 12.13 InSphero: Recent Developments and Future Outlook

Please contact our Customer Support Center to get the complete Table of Contents